Altimmune, Inc. (ALT) vs Monopar Therapeutics Inc. (MNPR)
Altimmune, Inc. and Monopar Therapeutics Inc. are both Biotechnology companies. Altimmune, Inc. and Monopar Therapeutics Inc. are of similar size ($602.8M and $593.3M). Across the 10 metrics below, Monopar Therapeutics Inc. leads on 8 and Altimmune, Inc. on 2.
Valuation
Profitability
| Metric | ALT | MNPR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (28.87%) | (19.50%) | (57.72%) |
| Return on assets | (25.58%) | (18.90%) | (49.22%) |
| Return on invested capital | (34.30%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack